Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A De Man

Showing results (161-170 of 543) with videos related to

Pageof 55
Sort By:
Journal of Hepatology|February 24, 2009
Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapyJurriën G P Reijnders, Suzan D Pas, Martin Schutten, et al.
Gut|June 15, 2007
Accuracy of a referral guideline for patients with chronic hepatitis B in primary care to select patients eligible for evaluation by a specialistIrene K Veldhuijzen, Marijke C Mostert, Hubert G M Niesters, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 31, 2011
[Rheumatic diseases need more attention in case of the desire to have children and during pregnancy]Yaël A de Man, Radboud J E M Dolhain, Eric A P Steegers, et al.
Endoscopy|April 1, 2015
Reply to Konge et alVivian E Ekkelenkamp, Erik A J Rauws, Robert A de Man, et al.
Gastrointestinal Endoscopy|December 6, 2014
Simulated colonoscopy training leads to improved performance during patient-based assessmentArjun D Koch, Vivian E Ekkelenkamp, Jelle Haringsma, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 20, 2002
The dynamics of mutations in the YMDD motif of the hepatitis B virus polymerase gene during and after lamivudine treatment as determined by reverse hybridisationSuzan D Pas, Robert A de Man, Edwin Fries, et al.
Therapeutic Advances in Gastroenterology|July 2, 2019
The efficacy and safety of rifaximin-α: a 2-year observational study of overt hepatic encephalopathyRosalie C Oey, Lennart E M Buck, Nicole S Erler, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 18, 2005
Quantification of the newly detected lamivudine resistant YSDD variants of Hepatitis B virus using molecular beaconsSuzan D Pas, Suwanna Noppornpanth, Annemiek A van der Eijk, et al.
European Journal of Internal Medicine|September 26, 2021
Should we continue surveillance for hepatocellular carcinoma and gastroesophageal varices in patients with cirrhosis and cured HCV infection?Cas J Isfordink, Raoel Maan, Robert A de Man, et al.
Digestive Diseases and Sciences|October 28, 1998
Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapyF ter Borg, S Smorenburg, R A de Man, et al.
Pageof 55

Showing results (161-170 of 543) with videos related to

Sort By:
Pageof 55
Journal of Hepatology|February 24, 2009
Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapyJurriën G P Reijnders, Suzan D Pas, Martin Schutten, et al.
Gut|June 15, 2007
Accuracy of a referral guideline for patients with chronic hepatitis B in primary care to select patients eligible for evaluation by a specialistIrene K Veldhuijzen, Marijke C Mostert, Hubert G M Niesters, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 31, 2011
[Rheumatic diseases need more attention in case of the desire to have children and during pregnancy]Yaël A de Man, Radboud J E M Dolhain, Eric A P Steegers, et al.
Endoscopy|April 1, 2015
Reply to Konge et alVivian E Ekkelenkamp, Erik A J Rauws, Robert A de Man, et al.
Gastrointestinal Endoscopy|December 6, 2014
Simulated colonoscopy training leads to improved performance during patient-based assessmentArjun D Koch, Vivian E Ekkelenkamp, Jelle Haringsma, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 20, 2002
The dynamics of mutations in the YMDD motif of the hepatitis B virus polymerase gene during and after lamivudine treatment as determined by reverse hybridisationSuzan D Pas, Robert A de Man, Edwin Fries, et al.
Therapeutic Advances in Gastroenterology|July 2, 2019
The efficacy and safety of rifaximin-α: a 2-year observational study of overt hepatic encephalopathyRosalie C Oey, Lennart E M Buck, Nicole S Erler, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 18, 2005
Quantification of the newly detected lamivudine resistant YSDD variants of Hepatitis B virus using molecular beaconsSuzan D Pas, Suwanna Noppornpanth, Annemiek A van der Eijk, et al.
European Journal of Internal Medicine|September 26, 2021
Should we continue surveillance for hepatocellular carcinoma and gastroesophageal varices in patients with cirrhosis and cured HCV infection?Cas J Isfordink, Raoel Maan, Robert A de Man, et al.
Digestive Diseases and Sciences|October 28, 1998
Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapyF ter Borg, S Smorenburg, R A de Man, et al.
Pageof 55